4 things you need to know about the administration’s latest Part B proposal

______________________________________________________________________________________________

The Department of Health and Human Services (HHS) recently released an Advance Notice of Proposed Rulemaking regarding Medicare Part B that puts patient access to medicines and Part B at risk. Referred to as the International Pricing Index Model, the proposal would use the Center for Medicare & Medicaid Innovation (CMMI) to test a mandatory demonstration that would set U.S. prices for medicines based on the pricing policies of foreign governments. With all the ongoing conversations about this proposal, we wanted to set the record straight on a few key points. The International Pricing Index Model for Part B would: